Friday, 22 December 2017

COLD TRANSMUTATION OF CHEMICAL ELEMENTS AND THE ICO


It is observed that the demands for high quality and stable elements like palladium, iridium, rhodium, platinum, e.t.c are at a high rate. The demands for isotopes of chemical elements are also high. It is also known that these high quality and valuable elements are not evenly distributed across the globe by nature. As a result of these high demands for quality and stableelements, a group of researchers designed a platform called Synthestech technology with the main objective of creating valuable elements and isotopes from cheap elements of lower grades by means of lower energy nuclear reactions (LENR) and to develop a precise techniques that is economical, commercially profitable for cold transmutation of chemical elements. Transmutation is the process of transforming low grade elements into a higher grade element that is needed by the industries for useful purposes. https://synthestech.com.Thisproject will involve three (3) main areas. One of them is the transmutation of low valued starting elements in order to obtain high quality element like rhenium, osmium, platinum, palladium, gold, rhodium, ruthenium e. t. c as final product. The second area is the transmutation of low valued starting elements in order to obtain a standard isotope mixtures and individual isotopes of stable elements. Finally, is the transmutation of various starting elements in order to obtain bioactive elements for medical use. To achieve all these SYNTHESTECH will analyze all processes involved in the transmutation processes. Synthestech technology will select the most technologically and commercially promising techniques for the conversion of some elements into another useful form. Synthestech will also develop the maximum conditions for specific low energy nuclear reactions (LENR) transmutation reactions.
There will also be development and examination of different innovations of reactors for cold transmutation of elements. Finally, synthestech will produce a pilot batch of artificially produced elements. The reasons behind this project are that the elements that are produced through the cold transmutations processes are stable; they are at a cheaper rate, since the process is economical. The elements also have proven high energy potentials. The elements obtained through this cold transmutation process also have powerful biogenic effects. The elements also increase life expectancy. Synthestech hereby invites investors to key in into this world class project by partnering with the funding of the project to build the synthestech laboratory and for the buying of the scientific equipments needed. Investors are hereby encouraged to participate in the token generation event (TGE).The name of the synthestech token is called TICKER STT. The token will be on the ethereum network. Bitcoin and ethers will be accepted during the token sale. The token sale will be managed by a company called Swiss Isotopes SARL. The equivalent rate of one STT is equal to one USD (1TT is equivalent to 1USD). The total token available for sale is 18,000 000 STT tokens. The mode of payments to the token holders will be automatically to the address of ethereum wallet which is in use at the time of payment at the current cryptocurrency exchange rate of ethereum to US dollar. The STT token sale is divided into private pre sale, pre ICO and ICO. Any purchase of the token during the pre sale stage attracts a 25% bonus package. Participants of the private sales at any stages get a mouth watering bonus of 50% bonus package of investment amount. The pre ICO and private sale started December, 2017 and will end in January, 2018. The ICO sale will start February, 2018 and also end in February, 2018. As a wise investor don’t afford to miss this opportunity. Hurry now and buy your tokens. The implementation of this project work will start from April and end in June, 2018. The mastering of the technologies involved in cold transmutations for commercial use will start June 2018 and end June, 2019. Receiving of dividends from investments will be in January 2020.
AUTHORED BY
0x9aB7005af9630f0EbEEE596Dce70498E682e8042

No comments:

Post a Comment